Confirmed cases of coronavirus are beginning to taper off even as nationwide testing surges – however, hospitalizations linked to the virus hit a new record high this week.
As of November 30, 2020, a total of 96,039 Americans were hospitalized with the virus – up 102.6 percent from the 47,402 who were hospitalized a month ago.
Obviously, that is placing a monumental strain on America’s already overtaxed health care delivery system.
The good news? Despite a huge ramp-up in nationwide testing, the number of new cases appears to be slowing somewhat – although it remains to be seen whether this is just a late fall pause prior to the “dark winter” promised by presumed U.S. president-elect Joe Biden.
As of November 30, the rolling seven-day average of new confirmed cases stood at 160,743 per day – down from a record high of 177,981 on November 25.
Deaths associated with the virus have experienced a modest uptick over the last few weeks – with the seven-day rolling average of new deaths registering 1,431 per day as of November 30.
While that number is significantly higher than it was during the summer surge of the virus, it remains well below the daily death counts that were recorded between early April and mid-May – the peak of the first wave of the virus.
As a result, the case fatality rate associated with Covid-19 currently stands at 2 percent – a third of what it was back in mid-May.
Also, as we have said from the very beginning of this pandemic, if you are young and in relatively good health – this virus is not targeting you.
According to the latest provisional data from the U.S. Centers for Disease Control and Prevention (CDC), 31.1 percent of all deaths “involving” Covid-19 were among Americans 85 years of age or older. Another 26.8 percent were among Americans between the ages of 75-84. Meanwhile, 21.5 percent were among Americans between the ages of 65-74.
All told, that’s 79.4 percent of all Covid-19-involved fatalities.
Conversely, only 8.05 percent of deaths “involving” Covid-19 were among Americans aged 54 or younger.
All of those numbers are roughly where they were when we last reported on this breakdown two weeks ago. As we noted at the time, “any loss of life related to the virus is a tragedy” – however we believe it is important to report on this data as it provides context for risk.
As we continue to track the latest data regarding the pandemic, there is additional good news to report this week regarding potential Covid-19 vaccines.
Pfizer previously requested such authorization prior to the Thanksgiving holiday.
According to reporter Jon Cohen of Science Mag, the Moderna vaccine – developed with financial support from the administration of U.S. president Donald Trump – reported a 94.1 percent efficacy rate against the virus and a 100 percent efficacy rate against “severe” Covid-19 cases.
“What we’ve seen so far is absolutely remarkable,” one vaccine researcher (and FDA advisor) told Science Mag regarding the Moderna drug.
Obviously deploying vaccines en masse will take several months to accomplish, meaning we should not expect to see them readily available to the public until mid-to-late winter at the earliest.
WANNA SOUND OFF?
Got something you’d like to say in response to one of our stories? We have an open microphone policy! Submit your own letter to the editor (or guest column) via-email HERE. Got a tip for a story? CLICK HERE. Got a technical question or a glitch to report? CLICK HERE.